Infinity Optics Solutions

Infinity Optics Solutions is a Singapore registered independent company formed and incorporated in October 2014.

The Company has developed, patented and trademarked – QuantumCryptTM, which encompasses the Next Generation of Advanced Identity Solution that will protect privacy in biometric enabled digital identity and personalization solutions for financial/government institutions, security as a service and other various digital identity applications. The core technology removes the need to store biometric image or template which traditionally is required for matching, enables the cancellation of biometric registration in the event of a data breach and is easily integrated with anti-spoof or liveness detection capabilities. The technology is designed to ensure that users’ biometric information will always remain private to the individual and should there be any compromise in the stored user’s login credentials that would identify and verify users, users can revoke and re-enrol themselves again. Also, the technology can ensure digital hygiene in digital identity applications on local premise or cloud-based solutions.

The Company is solving the biggest pain points in biometrics deployment in the digital identity space. The technology reduces the risk of identity theft and fraud resulting from data breaches by removing any stored biometric data or biometric template. It also reduces the high costs and complexities by many companies in attempting to protect and store the biometric templates that are traditionally required for authentication by users. By encrypting the biometric data, there are potential risks for hackers to retrieve users’ biometric information (previously enrolled and stored biometric images or digital codes) in the process that can compromise the user’s biometric information.

The Company signed a partnership agreement with one of the largest global fingerprint

technology company and was awarded “The Frost & Sullivan 2020 Global Most

Innovative Biometric Technology”.

Having developed the QuantumCryptTM technology for biometric authentication for both fingerprint and iris, the company is broadening their enabling technology to other biometric modalities such as – Face (both 2D and 3D), palm print/scan and voice recognition; and seeking Israeli partners that have these capabilities. They will co-develop the solutions with their first customer that is a global healthcare digital service provider and also a mobile-enabled solution provider (both solutions integrated). The customer is convinced that a solution that would encompass a suite of biometric modalities would be able to improve on the privacies and securities of patients’ data and other healthcare-related applications.

Besides the healthcare opportunity, there are also global initiatives that have been set up (i.e.

Singapore and Israel government agencies; or international system integrators) that are looking for a workable solution that would be able to protect the privacy and securing of confidential information, therefore, the company believes that the Israeli partner would be able to benefit in this very scalable opportunities (both locally and globally).

Infinity Optics Solutions will be providing the proprietary enabling software technology to extract stable and repeatable features from most physiological biometric without the need to record any biometric image nor store any sensitive data. This allows direct encryption of the identification/verification information of an individual or persons.

The partnering company would require having expertise in facial biometric (2D or 3D)
and palm print biometric authentication, voice recognition and also companies
specializing in liveness detection/anti-spoof solutions.

The partnering company shall work with Infinity Optics Solutions to integrate/develop the QuantumCryptTM technology to be incorporated into their biometric authentication platform and identification/verification architecture. The complete suite of solutions will be presented to the end customer for a front to end-point total integration into their healthcare system for both local premise and cloud.